Amplimmune, Inc.
5Patents
5Active
5Granted
50Portfolio score
Filing activity: Aug 25, 2009 → Dec 20, 2011 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8609089B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 131 | Active |
| US8709416B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 86 | Active |
| US8114845B2 | Compositions of PD-1 antagonists and methods of use | Emerging Cross-Sectional Technologies | 68 | Active |
| US9005616B2 | Methods and compositions for the inhibition of transplant rejection | Physics | 6 | Active |
| US9011853B2 | B7-H4 fusion proteins and methods of use thereof | Physics | 5 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.